Movatterモバイル変換


[0]ホーム

URL:


GB9127531D0 - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
GB9127531D0
GB9127531D0GB919127531AGB9127531AGB9127531D0GB 9127531 D0GB9127531 D0GB 9127531D0GB 919127531 AGB919127531 AGB 919127531AGB 9127531 AGB9127531 AGB 9127531AGB 9127531 D0GB9127531 D0GB 9127531D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919127531A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co LtdfiledCriticalFujisawa Pharmaceutical Co Ltd
Priority to GB919127531ApriorityCriticalpatent/GB9127531D0/en
Publication of GB9127531D0publicationCriticalpatent/GB9127531D0/en
Priority to EP93900373Aprioritypatent/EP0620818A1/en
Priority to PCT/JP1992/001674prioritypatent/WO1993013099A1/en
Priority to JP5511550Aprioritypatent/JPH08500082A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB919127531A1991-12-311991-12-31Heterocyclic compoundPendingGB9127531D0 (en)

Priority Applications (4)

Application NumberPriority DateFiling DateTitle
GB919127531AGB9127531D0 (en)1991-12-311991-12-31Heterocyclic compound
EP93900373AEP0620818A1 (en)1991-12-311992-12-21ARYL KETONES AS TESTOSTERONE 5$g(a)-REDUCTASE INHIBITORS
PCT/JP1992/001674WO1993013099A1 (en)1991-12-311992-12-21ARYL KETONES AS TESTOSTERONE 5α-REDUCTASE INHIBITORS
JP5511550AJPH08500082A (en)1991-12-311992-12-21 Aryl ketones as testosterone 5α-reductase inhibitors

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB919127531AGB9127531D0 (en)1991-12-311991-12-31Heterocyclic compound

Publications (1)

Publication NumberPublication Date
GB9127531D0true GB9127531D0 (en)1992-02-19

Family

ID=10706912

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB919127531APendingGB9127531D0 (en)1991-12-311991-12-31Heterocyclic compound

Country Status (4)

CountryLink
EP (1)EP0620818A1 (en)
JP (1)JPH08500082A (en)
GB (1)GB9127531D0 (en)
WO (1)WO1993013099A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0783488A4 (en)*1994-09-271998-01-07Ono Pharmaceutical CoFive membered heterocyclic compounds
US5859042A (en)*1995-09-271999-01-12Ono Pharmaceutical Co., Ltd.Five membered heterocyclic compounds
JPH10182546A (en)*1996-12-251998-07-07Kotobuki Seiyaku KkAzulene derivative, its production and medicine containing the same
US6900236B1 (en)1999-10-182005-05-31University Of ConnecticutCannabimimetic indole derivatives
CA2436133A1 (en)2001-01-292002-08-08University Of ConnecticutReceptor selective cannabimimetic aminoalkylindoles
US7632955B2 (en)2001-12-132009-12-15National Health Research InstitutesIndole compounds
US7528165B2 (en)2001-12-132009-05-05National Health Research InstitutesIndole compounds
US7504509B2 (en)2003-12-192009-03-17Plexxikon, Inc.Compounds and methods for development of Ret modulators
US7498342B2 (en)2004-06-172009-03-03Plexxikon, Inc.Compounds modulating c-kit activity
TW200621237A (en)2004-11-012006-07-01Wyeth Corp[(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones
US7456289B2 (en)2004-12-312008-11-25National Health Research InstitutesAnti-tumor compounds
US7501438B2 (en)2006-07-072009-03-10Forest Laboratories Holdings LimitedPyridoimidazole derivatives
WO2008063888A2 (en)2006-11-222008-05-29Plexxikon, Inc.Compounds modulating c-fms and/or c-kit activity and uses therefor
CN101058558B (en)*2007-05-282013-04-10沈阳药科大学4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof
EP2170830B1 (en)2007-07-172014-10-15Plexxikon, Inc.2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS
ES2552386T3 (en)2009-04-032015-11-27F. Hoffmann-La Roche Ag Propane-1-sulfonic acid {3- [5- (4-chloro-phenyl) -1H-pyrrole [2,3-b] pyridin-3-carbonyl] -2,4-difluoro-phenyl} -amide compositions and uses thereof
EA201290210A1 (en)2009-11-062012-10-30Плексксикон, Инк. CONNECTIONS AND METHODS OF KINASE MODULATION AND INDICATIONS FOR THEIR APPLICATION
SMT201900112T1 (en)2011-02-072019-02-28Plexxikon IncCompounds and methods for kinase modulation, and indications therefor
AR085279A1 (en)2011-02-212013-09-18Plexxikon Inc SOLID FORMS OF {3- [5- (4-CHLORINE-PHENYL) -1H-PIRROLO [2,3-B] PIRIDINA-3-CARBONIL] -2,4-DIFLUOR-PHENIL} -AMIDE OF PROPANE ACID-1- SULFONIC
US9150570B2 (en)2012-05-312015-10-06Plexxikon Inc.Synthesis of heterocyclic compounds
WO2016044445A2 (en)2014-09-172016-03-24Ironwood Pharmaceuticals, Inc.sGC STIMULATORS
US10844064B2 (en)2014-09-172020-11-24Cyclerion Therapeutics, Inc.sGC stimulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB9004301D0 (en)*1990-02-261990-04-18Fujisawa Pharmaceutical CoIndolebutyric acid derivatives and process for preparation thereof
GB9011335D0 (en)*1990-05-211990-07-11Fujisawa Pharmaceutical CoIndolebutyric acid derivatives and process for preparation thereof

Also Published As

Publication numberPublication date
WO1993013099A1 (en)1993-07-08
JPH08500082A (en)1996-01-09
EP0620818A1 (en)1994-10-26

Similar Documents

PublicationPublication DateTitle
GB9125001D0 (en)Heterocyclic compounds
GB9105677D0 (en)Heterocyclic compounds
GB9127531D0 (en)Heterocyclic compound
GB9113626D0 (en)Heterocyclic compounds
GB9205484D0 (en)Heterocyclic compounds
GB9121727D0 (en)Heterocyclic compounds
GB9205507D0 (en)Heterocyclic compounds
GB9104838D0 (en)Heterocyclic compounds
GB9111131D0 (en)Heterocyclic compounds
GB9104832D0 (en)Heterocyclic compounds
GB9123916D0 (en)Heterocyclic compounds
GB9104769D0 (en)Heterocyclic compounds
GB9205485D0 (en)Heterocyclic compounds
GB9205487D0 (en)Heterocyclic compounds
GB9117987D0 (en)Heterocyclic compounds
GB9204859D0 (en)Heterocyclic compounds
GB9121316D0 (en)Heterocyclic compounds
GB9106714D0 (en)Heterocyclic compounds
GB9121148D0 (en)Heterocyclic compounds
GB9106655D0 (en)Heterocyclic compounds
GB9106656D0 (en)Heterocyclic compounds
GB9106605D0 (en)Heterocyclic compounds
GB9106715D0 (en)Heterocyclic compounds
GB9108217D0 (en)Heterocyclic compounds
GB9108358D0 (en)Heterocyclic compounds

[8]ページ先頭

©2009-2025 Movatter.jp